Exploring the Boundaries of Medulloblastoma Subgroups with Synthetic Data Generation
Preprint
Abstract
Medulloblastoma is a childhood brain tumor traditionally classified into four molecular subgroups. Recent evidence suggests that Groups 3 and 4 represent a biological continuum rather than distinct entities, a paradigm shift with significant implications for understanding disease biology and treatment strategies. Nevertheless, assessing this hypothesis is challenging mainly due to data scarcity. In this study, we utilize transcriptomics data to provide evidence supporting the existence of an intermediate subgroup between Groups 3 and 4 with distinct molecular features. Leveraging synthetic data generation with a Variational Autoencoder, we address data scarcity limitations effectively. Our findings are corroborated by prior studies employing different methodologies and datasets, further reinforcing the robustness of our results. Additionally, we apply explainability techniques to the VAE, uncovering key relationships between gene expression and disease subgroups. This study demonstrates the potential of synthetic data generation to refine rare disease subtyping and advance our understanding of the underlying biological mechanisms.Keywords
This publication has 81 references indexed in Scilit:
- An Efficient and Reliable scRNA-seq Data Imputation Method Using Variational Autoencoders2024
- Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentCell Reports, 2022
- Crash data augmentation using variational autoencoderAccident Analysis & Prevention, 2021
- Artificial intelligence in cancer research: learning at different levels of data granularityMolecular Oncology, 2021
- Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesActa Neuropathologica, 2019
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2018
- Intertumoral Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2017
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011